Ledger.Open graph →
SEC Form D · filed October 4, 2016

SQZ Biotechnologies Co

Offering
$15.7M
Sold
$15.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boston, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Armon Sharei, Ph.D · Boston, MAExec · DirectorAmy W. Schulman · Boston, MAExec · DirectorKlavs F. Jensen, Ph.D · Boston, MADirectorJonathan Fleming · Boston, MADirectorGarry W. Nicholson · Boston, MADirectorEric W. Moessinger · WATERTOWN, MADirectorThomas B. Jahncke · IRVINE, CADirectorPassco Lone Oak Depositor, LLC · IRVINE, CAExec · DirectorLarry K. Sullivan · IRVINE, CADirectorMark W. Murcko, Ph.D · WATERTOWN, MADirectorHoward W. Bernstein · Boston, MAExecKris W. Elverum · Boston, MAExecRobert Langer, Sc.D · Boston, MADirectorCraig V. Jorasch · LOS ANGELES, CAExec · DirectorAlexander Weiss · Torrance, CADirectorCharles V. Moore · LOS ANGELES, CADirectorPassco Lone Oak Manager, LLC · IRVINE, CAExec · DirectorGarry W. Nicholson · Boston, MADirectorMark W. Murcko, Ph.D · WATERTOWN, MADirectorHoward W. Bernstein · Boston, MAExecKris W. Elverum · Boston, MAExecEric W. Moessinger · WATERTOWN, MADirectorRobert Langer, Sc.D · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗